.Nature Medication, Published online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antibody-- medication conjugate (ADC) tisotumab vedotin led to boosted progression-free and overall survival, triggering FDA commendation and also a brand-new therapy alternative for patients.